AnalystBook Research · Company Intelligence

GE HealthCare Technologies Inc.

GEHCNasdaq

Built from GE HealthCare Technologies Inc.'s own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

The read at a glance

Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.

  • Distress risk · Altman Z-Score 2.37 grey zone — between safe and distressedWatch
  • Earnings-manipulation signal · Beneish M -2.11 no flag raisedOK

Where the revenue comes from

Fiscal 2025, as GE HealthCare Technologies Inc. reports it. History and quarterly detail are in the app.

  • Imaging$9.2B
  • AVS$5.4B
  • PCS$3.1B
  • PDx$2.9B

Leadership changes

From GE HealthCare Technologies Inc.'s own filings, the day they're filed.

  • Kevin A. Lobo · director · appointmenteff. 2026-03-13
  • Risa Lavizzo-Mourey · departureeff. 2026-03-13
  • Tomislav Mihaljevic · departureeff. 2026-03-13

Latest filings

  • 8-K · Company announcement2026-08-18
  • 10-Q · Quarterly report2026-07-29
  • 8-K · Company announcement2026-07-29
  • 8-K · Company announcement2026-07-29
  • 8-K · Company announcement2026-07-23
In the full recordFree for 14 days
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about GE HealthCare Technologies Inc., every answer cited to the official filings🔒
  • The Intelligence Brief — added when GE HealthCare Technologies Inc.'s brief passes our SEC-figure check🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.